在肠道瘤开始时,APC突变细胞作为超级竞争者
Sanne M van Neerven1,2, Nina E de Groot1,2, Lisanne E Nijman1,2
1Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Nature
|June 3, 2021
概括
突变肠干细胞 (ISC) 通过分泌WNT抗体来消除健康的邻居. 化治疗抑制了这种扩散, 这表明在高危人群中预防结肠癌的策略.
科学领域:
- 细胞生物学
- 癌症生物学
- 胃肠病学
背景情况:
- 肠道干细胞 (ISC) 需要一个平衡的WNT信号来更新肠道内.
- APC瘤抑制基因的突变破坏了这种平衡,导致WNT通路激活和结肠癌.
- 与野生型ISC相比,APC突变细胞具有竞争优势,通常导致克隆扩张和癌症发病.
研究的目的:
- 研究APC突变ISC的竞争优势背后的机制.
- 为了确定APC突变是否积极消除野生类型的邻居,
- 探索针对ISC竞争的治疗策略,以预防结肠癌.
主要方法:
- 在肠道中研究了APC突变和野生型ISC.
- 分析了WNT对手在ISC竞争中的作用.
- 使用化治疗来评估其对APC突变克隆扩张和腺瘤形成的影响.
主要成果:
- 通过分泌WNT抗体,诱导邻近的野生型ISC的分化,作为超级竞争者.
- 化治疗阻止了APC突变克隆的扩张和腺瘤的形成.
- 这种效应是通过通过GSK3β抑制和下游WNT激活使野生型ISC对WNT抗剂不敏感的.
结论:
- 具有APC突变的ISC积极消除野生类型的邻居,从而有助于它们的竞争优势.
- 通过调节WNT信号来增强健康细胞的健康,
- 针对ISC竞争对于患结肠癌高风险的人来说可能是一种新的治疗方法.
相关概念视频
Abnormal Proliferation
4.8K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Cancers Originate from Somatic Mutations in a Single Cell
13.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.4K
Renewal of Intestinal Stem Cells
2.8K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.8K
Metastasis
5.9K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.9K
Adaptive Mechanisms in Cancer Cells
6.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Tumor Progression
6.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.7K


